Read + Share
Papp K, Szepietowski JC, Kircik L, Toth D, et al. Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis:
Results From Two Phase 3 Studies. J Am Acad Dermatol 2022 Nov 26:S0190-9622(22)03136.
PMID: 36574595
|
 |
|
Papp K, Szepietowski JC, Kircik L, Toth D, et al. Long-Term Safety and Disease Control With Ruxolitinib Cream in Atopic Dermatitis:
Results From Two Phase 3 Studies. J Am Acad Dermatol 2022 Nov 26:S0190-9622(22)03136.
PMID: 36574595
|
|
|
|